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Abstract 9 
Recent advances in tissue engineering and regenerative medicine have shown that controlling cells 10 
micro-environment during growth is a key element to the development of successful therapeutic 11 
system. To achieve such control, researchers have first proposed the use of polymeric scaffolds that 12 
were able to support cellular growth and, to a certain extent, favor cell organization and tissue 13 
structure.  With nowadays availability of a large pool of stem cell lines, such approach has appeared to 14 
be rather limited since it does not offer the fine control of the cell micro-environment in space and time 15 
(4D). Therefore, researchers are currently focusing their efforts in developing strategies that include 16 
active compound delivery systems in order to add a fourth dimension to the design of 3D scaffolds. This 17 
review will focus on recent concepts and applications of 2D and 3D techniques that have been used to 18 
control the load and release of active compounds used to promote cell differentiation and proliferation 19 
in or out of a scaffold. We will first present recent advances in the design of 2D polymeric scaffolds and 20 
the different techniques that have been used to deposit molecular cues and cells in a controlled fashion. 21 
We will continue by presenting the recent advances made in the design of 3D scaffolds based on 22 
hydrogels as well as polymeric fibers and we will finish by presenting some of the research avenues that 23 
are still to be explored.  24 
 25 
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Introduction 29 
Driven by the increasing demand of organ transplantation, tissue engineering and more recently regenerative 30 
medicine have developed numerous strategies to grow such organs in vivo or ex vivo. After more than two decades 31 
of intense research, it is clear that organ engineering requires the use of a scaffold that serves as a synthetic 32 
extracellular matrix (ECM) to support and organize cell growth [1-4]. With the increasing number of available 33 
biomaterials that possess all the desirable properties required for tissue engineering as well as the constantly 34 
widening spectrum of manufacturing techniques to generate complex and finely tuned structures, researchers have 35 
been able to develop a tremendous variety of materials and scaffolds designed for specific tissues and applications 36 
[5-8]. Within the last few years, the use of stem cells in regenerative medicine and tissue engineering has become 37 
predominant [9-13]. Building a suitable micro-environment for their differentiation and proliferation is a challenging 38 
task. The rational design of such micro environment must involve a combination of many different expertises such 39 
as material micro-engineering, biological engineering and more recently pharmaceutical technology. The 40 
requirement of such diverse set of expertise has been driven by the intrinsic behavior of stem cells in their 41 
environment [14, 15]. Stem cells are present in many different places in any mammalian organism. They are 42 
inherently sensitive to many biophysical as well as biochemical stimuli generated from their direct surroundings 43 
[16]. Their differentiation and proliferation is not only dictated by very specific molecules such as growth factors 44 
but also by the concentration of such factors and their spatiotemporal distribution in the surroundings [17, 18].  It is 45 
believed that these spatiotemporal distributions (also called niche) of key factors are paramount elements 46 
determining cell recruitment, migration, proliferation, protein production and finally organ architecture [19, 20]. 47 
Artificially reproducing such complex dynamic environment is the main goal of nowadays tissue engineering 48 
research and the main focus of this review article.  49 
Early studies in tissue engineering predominantly used 2D polymeric scaffolds functionalized with adhesives 50 
molecules in order to mimic the interactions between cells and the ECM [21, 22]. In parallel, 2D devices such as 51 
patches, micro-electro-mechanical-systems or microchips were already reported for the controlled delivery of 52 
actives compounds (AC) [23-25]. It is only recently that these two worlds have collided and nurtured each other 53 
beneficially. To better mimic biological tissues, the transition from 2D to 3D scaffolds has become a necessary step. 54 
Interestingly, the tremendous large body of AC delivery systems using 3D devices such as particles or 55 
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macromolecules have not been fully explored in tissue engineering. This provides an excellent opportunity for 56 
development and promising future discoveries. 57 
Part I: 2D Tissue Engineering  58 
A. Distribution control of molecular cues in 2D 59 
It is well known that most of human body organs and tissues have a 3D structure while some other important body 60 
tissues such as blood and lymphatic vessels have a 2D structure. Therefore, engineering of tissues in 2D has proven 61 
to be of importance. For this purpose, different technologies in the realm of AC release and cell delivery have 62 
emerged in the past few years which we discuss here the most relevant ones (see figure 1). 63 
1. Gradient technology 64 
Tissue engineering and regenerative medicine deal directly with ECM, which carries various macromolecules or 65 
proteins such as growth factors and chemokines. Their physiological functions such as wound healing and 66 
morphogenesis are majorly regulated by molecular concentration gradient phenomena. Many studies related to 67 
cellular processes such as in vitro migration, signal transmission, cellular proliferation, viability had shown the 68 
significance of using gradient materials in tissue engineering [26, 27].  69 
Developing molecular gradients in a material can be extremely challenging especially when it comes to fine 70 
controlling. Ostrovidov et al. [28] have developed a microfluidic device acting as concentration gradient generator. 71 
The device made from micro-engineered poly(ethylene glycol) diacrylate (PEGDA) hydrogel contains concentration 72 
gradient of okadaic acid as a model drug released by diffusion. The authors showed that the drug gradient was able 73 
to modulate the viability of MC3T3 cells. 74 
Controlling the distribution of AC is not the only benefit of using gradient technology. The mechanical properties of 75 
a cell substrate can be controlled as well.  In vitro techniques based on photolithography [29] or on polymerization 76 
of adjoining solutions with variable concentrations [30] in order to obtain crosslinking density gradients have shown 77 
that it is possible to achieve good control over the elastic properties of a substrate in 2D. 78 
In a recent study, Tse et al. [31] have discussed whether undifferentiated mesenchymal stem cells (MSCs) can 79 
experience durotaxis in the absence of any pathological stimulation under exposure to a physiological stiffness 80 
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gradient. The authors created crosslinking gradient in polyacrylamide hydrogels using radial greyscale pattern with a 81 
photomask. In addition, type-I collagen was added to the gradient hydrogel to allow MSCs attachment. Results 82 
evidenced that MSCs were subjected to durotaxis on substrates with stiffness gradient values within physiological 83 
range and initiated differentiation at the stiffest regions instead of remaining in stationary position as had been 84 
hypothesised. 85 
2. Patterning technology 86 
The ability to spatially deposit and control the release of AC of variable size, including drugs and growth factors 87 
from patterned biomaterials is crucial to the development of bioactive surfaces for regenerative medicine. One of the 88 
scalable methods in patterning such surfaces is lithography. Stern et al. [32] have used patterned electropolymerized 89 
polypyrroles surfaces to attach and release AC such as ovalbumin and interleukin-2 respectively. These proteins act 90 
as vaccine components for binding to dendritic cells that process the antigen and present it to T-cell surface. The 91 
patterning was obtained by deposing photoresistant masks on the conductive substrate where electropolymerization 92 
of the dissolved monomers containing the AC took place.  The authors showed that surface patterning offered a very 93 
high control of the spatial distribution of the AC while their release rate was electrically controlled. 94 
Recent advancement in nanopaterning opens the opportunity to combine colloidal lithography and surface-initiated 95 
atom-transfer radical polymerization to finely control molecular cues distribution such as cell adhesive proteins. Li 96 
et al. [33] used hierarchical polymer brush nanopatterns to graft fibronectin on a planar substrate. As a result, 97 
fibronectin was covalently immobilized and showed biological activity without denaturation. Furthermore, MC3T3-98 
E1 mice osteoblasts had cohered to fibronectin patterns immediately and displayed uniformity along the stripes, 99 
which suggest that these protein patterns are excellent candidates for cell patterning.  100 
Thissen et al. [34] have recently described a method based on surface patterning to control the growth of  bovine 101 
corneal epithelial tissue on surfaces by creating protein adsorbing and non-adsorbing sites via cell-collagen-I 102 
interactions. This manipulation was accomplished by applying a thin layer of acetaldehyde polymer coating 103 
(adhesive site for subsequent collagen I deposition) and poly(ethylene oxide) PEO (non-adhesive site) on the 104 
substrate.  105 
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Common lithographic patterning techniques require either UV exposure or jarring solvents, which are not suitable 106 
for most biomolecules. A new patterning technique that does not damage biomolecules was recently reported [35]. 107 
The process uses hydrofluoroether solvents which solubilise fluorinated UV resistant materials used to pattern AC 108 
through imprint lithography. Such process has been applied to protein and DNA patterning without damaging the 109 
AC. 110 
Alternatively, inkjet printing has been used to create spatial patterns of fibroblast growth factor-2 (FGF-2) on fibrin 111 
films for studying preosteoblastic cells response in vitro [36]. The authors showed that under cell culture conditions 112 
for over one week, printed patterns as well as FGF-2 remained persistent and active. 113 
Most of the previously described reports carry great potentials and opportunities for future development regarding 114 
tissue engineering. However, it has not been found yet advanced studies involving such methods upon major in vivo 115 
applications in regenerative medicine. 116 
B. Cell patterning and co-culture 117 
Spatial control of living cells distribution has attracted great attention due to its broad potential applications in 118 
regenerative medicine.  The development of microfabrication technology in the past decade has largely enriched cell 119 
patterning methods by introducing precise surface engineering, in which spatial patterning of cells is confined by 120 
regulating surface chemistry.  Cells are often patterned on a planar surface, which can be further controlled to 121 
prepare a 3D bioactive structure or scaffold. 122 
Inkjet printing method was reported as an advantageous technique for human fibroblast cells patterning. Using this 123 
method Saunders et al. [37] were able to create cells patterns on agarose gel without damaging the cells.  124 
In order to modify surface chemistry and to improve cell patterning, Chien et al. [38] have combined microcontact-125 
printing method with mussel inspired surface chemistry. Controlled imprints of polydopamine (PDA)/poly ethylene 126 
imine (PEI) were fabricated using poly(dimethylsiloxane) (PDMS) stamps. These imprints were used to control cell 127 
adhesion using the high binding affinity of PDA enhanced by deposition of PEI. In vitro tests conducted with co-128 
cultured hepatocytes and neural cells lead to spatially controlled distribution of cells. This technique could be used 129 
to favor cells adhesion at specific sites by recover them of cell adhesion promoting imprints. 130 
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In another study Tanaka et al. [39] discussed how to manage the PDMS stamping force and the importance of stamp 131 
stiffness to improve cell patterning. The authors reported a method to improve printing precision by controlling the 132 
stamp stiffness via microscope observation of stamp deformation due to the applied force. The proposed micro 133 
printing method gave a high printing quality with 2.5% error of micro stamping area and was tested by patterning 134 
GFP-HUVEC (GFP Expressing Human Umbilical Vein Endothelial Cells) and NIH/3T3 co culture on fibronectin 135 
covered substrates (see figure 2) 136 
C. 3D constructs based on 2D assemblies  137 
In the area of 3D microfabrication, a recent novel strategy based on 2D scaffold folding, which enables production 138 
of 3D microstructure simply by folding 2D sheets was recently reported [40]. Origami folding and polyhedral 139 
capsule rolls are two examples using such strategy [41].  140 
Bioartificial endocrine pancreas (BAEP) was created by encapsulating pancreatic B-cells for diabetes treatment 141 
purposes [42]. This BAEP was found more advantageous over gel encapsulation method in terms of mass transfer 142 
efficiency of AC due to its unique architectural design and geometry. The BAEP fabrication was based on folded 143 
polyhedral capsules wrapped up within an alginate sheet (see figure 3). Consequently, insulin release was confirmed 144 
suggesting that this approach could be convenient for regenerative medicine.  145 
This emerging technology is extremely promising due to its potential scalability, its versatility in terms of structures 146 
and materials that can be used. Such approach though, requires very specific expertises and equipment which limits 147 
its exploration and use at the present time. Instead, other approaches based on readily available materials such as 148 
hydrogels have attracted much more attention and will be described in the next section. 149 
Part II: Hydrogel scaffolds 150 
Techniques of 3D hydrogels scaffolding have been developed for two major regenerative medicine related purposes: 151 
cell viability, proliferation and differentiation as well as AC delivery [43]. This was commonly achieved by the 152 
incorporation of AC and/or cells inside the hydrogel matrix via different techniques leading to various architectures 153 
that can be used for diverse applications (see figure 4).  154 
A. Effect of active compounds loading and release 155 
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Incorporating an AC such as a growth factor, a drug or genetic material into a polymeric scaffold can be achieved by 156 
embedding this compound inside the scaffold using chemical or physical bounding [44]. Control over such bindings 157 
and loading mechanics is a key parameter to achieve simultaneous or sequential controlled release of multiple AC 158 
[45].  159 
Incorporation of an AC into a hydrogel matrix usually results in a fast release of the AC, at least during the initial 160 
period of the release (see figure 5). Such effect, known as initial burst effect is problematic for tissue engineering 161 
applications where long lasting delivery is often desirable. Tang et al. [46] have controlled the burst effect by 162 
embedding N-(2-hydroxyl) propyl-3-trimethyl ammonium chitosan chloride (HTCC) – carboxymethyl chitosan 163 
(CM) nanoparticles into chitosan/poly(vinyl alcohol) hydrogel by adding them prior to gelation. Propranolol, as 164 
positively charged model drug, diclofenac sodium, as negatively charged model drug, and nanoparticles were added 165 
prior to gelation. The authors obtained nanoparticles with different charges by varying the ratio between HTCC and 166 
CM. The interaction between the drug and the nanoparticles was shown to have a direct effect on the release. The 167 
release of the positively charged drug was found to be much slower in negatively charged hydrogel than in neutral 168 
hydrogel and vice versa. 169 
The controlled release of growth factors is crucial in regenerative medicine due to their roles as biological cues for 170 
cell fates. Pakulska et al. [47] have prepared chondroitinase ABC (ChABC), a promising therapeutic agent for spinal 171 
cord injury to a methylcellulose (MC) hydrogel by grafting a small protein domain (Src homology 3: SH3) on the 172 
AC and a binding peptide (weak or strong) on the hydrogel. The release rate of the AC was then tuned either by 173 
varying the SH3-protein/SH3-peptide pair binding strength or ratio. Even if the release process was disturbed by the 174 
thermal instability of ChABC at 37°C, the authors were able to observe a tunable release: 90% of release was 175 
obtained after 3 days for an unmodified MC hydrogel, while it decreased to 20% in 7 days with the strong ChABC-176 
SH3 binder and to 50% and 10% in 7 days with a weaker binder at respectively 100 and 300-fold molar excess of 177 
SH3 peptide to ChABC. 178 
AC release can be triggered by cell activity as well. Song et al. [48] have studied the effect of combining two AC 179 
(stromal derived factor 1: SDF-1 and angiogenic peptides: Ac-SDKP) in an acrylated hyaluronic acid hydrogel on a 180 
chronic myocardial infarction rat model. The authors loaded SDF-1 directly within the hydrogel and Ac-SDKP was 181 
bound to the polymer scaffold via thiol-acrylate reaction.  The release of SDF-1 and Ac-SDKP was triggered by the 182 
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action of matrix metalloproteinase (MMP) secreted by the surrounding cells or via hydrogel degradation. By 183 
providing an injectable 3D micro-environment to attract mesenchymal stem cells followed by growth factor release, 184 
this approach was found to promote stable vessels growth, and decreased fibrosis, which in turn leads to the 185 
recovery of heart function. Even if the mechanism of regeneration by SDF-1 and Ac-SDKP is still unclear, this 186 
study showed the strong positive synergistic effect of the two compounds. 187 
These recent examples show that AC controlled loading and release in hydrogel scaffold play a crucial role for the 188 
development of therapeutic implants. By tuning the hydrogel scaffold properties and especially the AC-matrix 189 
bounding, multiple and sequential releases of ACs can be envisaged. 190 
B. Effect of cells loading and culture  191 
Due to their internal structure that can be tuned to mimic the ECM, hydrogels were firstly used for cell 192 
immobilization [49]. With the development of tissue engineering and progress in hydrogel scaffolding, these 193 
materials are now able to promote cells growth, differentiation and organization [50, 51]. Such properties can be 194 
achieved via incorporation of cells into structured 3D hydrogel scaffolds in multiple ways depending on what the 195 
final goal or application is.  196 
Cell embedment in the hydrogel can be achieved by directly inserting the cells during the gelation process. Wright et 197 
al. [52] studied human corneal epithelial cells viability in a calcium alginate-hydroxyethyl cellulose hydrogel. After 198 
mixing the cells with the hydrogel solution, cells were found to survive the gelation process, and were viable up to 7 199 
days in ambient and chilled conditions, which makes this hydrogel potentially useful for cells transport and storage 200 
purposes. 201 
Such technique can also be used to highlight the role of the hydrogel composition on loaded cells fate. Li et al [53] 202 
used fluorinated methacrylamide chitosan hydrogels for neural stem cell differentiation. Neural cells were added 203 
with scaffold components prior to photopolymerization. The authors studied the proliferation and differentiation of 204 
neural cells in fluorinated methacrylamide chitosan hydrogels which had the ability to uptake oxygen from the 205 
environment or from supplemental oxygen. Fluorine moieties in the hydrogel were found to modulate oxygen 206 
uptake and release which resulted in improved cell proliferation and differentiation. 207 
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Introducing the receptor sites in the hydrogel is an easy way to increase the amount of introduced cells and to 208 
achieve a better control over their near environment. Halstenberg et al. [54] created an artificial protein with matrix 209 
degradation capacity containing two cell binding sites (RGD integrin-binding and heparin binding site), matrix 210 
degradation sites (two plasmin degradation sites) and an acrylate moiety. The authors used this protein in 211 
conjunction with poly(ethylene glycol) diacrylate to form a hydrogel. Human fibroblasts-fibrin clusters were 212 
embedded via cell solution deposition on the hybrid hydrogel. These clusters were used to assess cell attachment on 213 
3D binding sites, proliferation for at least 7-9 days in vitro and cell induced matrix degradation. Using the artificial 214 
protein resulted in an improved cellular penetration in the hydrogel due to the combination of cellular outgrowth and 215 
triggered matrix degradation. 216 
Incorporation of niches inside the hydrogel matrix prior to cell embedment was found to have positive effect on cells 217 
development. Hwang et al. [55] used gelatin beads (150-300µm) included in a cell laden alginate hydrogel, which 218 
after dissolution and washing left occlusions of controlled size. Use of such scaffolds in tissue engineering was 219 
tested using hepatocarcinoma cells (HepG2). The cells were positioned inside the cavities and significantly 220 
enhanced cell proliferation was observed compared to non porous scaffold, due to better mass transfer of nutrients, 221 
oxygen and waste removal through the hydrogel. 222 
C. Active carriers for tissue regeneration 223 
Cell fate in a tissue depends on two main factors: mechanical stress and cell-ECM biochemistry. Chemical 224 
interactions between cells and AC are based on 3D-signaling which is a result of AC spatiotemporal availability and 225 
cells motility. Active carriers for tissue regeneration combine cells encapsulation and triggered AC release to 226 
promote timed-control cell growth. 227 
Du et al. [56] obtained chitosan hydrogel exhibiting an interconnected network of cavities using 10 µm CaCO3 228 
microparticles encapsulation followed by gas foaming. After freeze-drying treatment of the hydrogel, the authors 229 
obtained a hierarchical porous structure later treated by layer-by-layer molecular deposition of oppositely charged 230 
chondroitin sulfate (CS) and chitosan to mimic the ECM. The hydrogel cavities were then loaded on their surface 231 
with fibroblast growth factor (FGF) via CS binding and then with human lung fibroblast cells. The authors showed 232 
that the architecture of the interconnected network of cavities did not have any significant effect on FGF cumulative 233 
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release but improved FGF loading resulting in a higher amount of FGF reaching encapsulated cells (see figure 6). 234 
The authors showed that combining the hierarchical porous structure of the chitosan hydrogel with the controlled 235 
loading and release of the growth factor via CS binding of FGF had a positive effect on human lung fibroblast 236 
growth. 237 
In another study, the same authors [57] used two growth factors that could be released successively. They 238 
incorporated two growth factors, native TGF-β and bFGF modified to specifically bind to collagen in a CS/collagen 239 
hydrogel. Such modification allowed the growth factor to be loaded in the scaffold to a much higher content and to 240 
be released much slower than TGF-β. These successive releases were used by the authors to induce differentiation of 241 
hMSCs into chondrocytes (see figure 7). 242 
Hydrogel scaffolds have been tested in vivo as well. Using direct loading of two growth factors (VEGF: vascular 243 
endothelial growth factor and IGF-1) in an alginate hydrogel precursors mix prior to gelation and followed by freeze 244 
drying to create a niche for myoblast encapsulation lead to a scaffold able to promote muscle regeneration. Borselli 245 
et al. [58] tested this hydrogel in the context of a severe injury to mice skeletal muscle tissue. A synergistic effect 246 
between VEGF and SDF-1was demonstrated on muscle growth in comparison to implantation of blank alginate 247 
scaffold or single growth factor loaded hydrogel. It was also shown that cell seeding in the hydrogel allows even 248 
better muscle regeneration. Even if the impact of such scaffold on the muscle size and weight was not always 249 
significant, it allowed an improved fiber growth and higher blood vessel density leading to normal tissue perfusion 250 
levels.  251 
It is possible also to pattern the hydrogel containing growth factors and cells before implantation in order to better 252 
mimic in vivo tissue organization. Chen et al. [59] have combined two genes (TGF-B1 and BMP-2) activated 253 
chitosan/gelatin scaffolds (freeze dried for mesenchymal stem cell loading) to create a bilayered hydrogel for 254 
articular cartilage and subchondral bone simultaneous regeneration. Once both scaffold were loaded with 255 
mesenchymal stem cells and have supported cells differentiation (chondrogenic and osteogenic respectively), they 256 
were glued together via fibrin glue. The bilayered materiel was tested on a rabbit knee defect and was found to 257 
perfectly support articular cartilage and subchondral regenerations, leading to complete repair. 258 
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The strategies described so far involve controlled but passive release of the AC. This is, in principle, not efficient to 259 
maximize contact of the AC with the surrounding cells. To overcome this problem Yang et al. [59] developed an 260 
active PEG scaffold able to release locally synthetic glucocorticoid Dexamethasone (DEX) only in presence of a 261 
neighboring cell. The authors conjugated DEX to the scaffold using a peptidic linker. The linker was degraded by 262 
production of matrix metalloproteinase from the proliferating hMSCs. This resulted in a localized stimulation of 263 
alkaline phosphatase (ALP) and calcium deposition for over 21 days whereas no elevated cellular responses were 264 
observed in co-cultured hMSCs surrounding the gel, suggesting possible applications in bone regenerative medicine.  265 
 266 
With their highly tunable internal structure, hydrogels are the main material used for scaffolding. Such scaffolds 267 
have various applications for regenerative medicine going from storage to multiple controlled releases of AC and/or 268 
cells. Even if some hydrogel scaffolding techniques are already commercially available, the innovations discussed 269 
above present promising future as therapeutic treatments. However hydrogel scaffolding is not the only solution for 270 
4D AC delivery, other materials are gaining interest, such as fibrous scaffolding. 271 
Part III: Fibrous scaffolds  272 
Fibrous scaffolds represent a popular substrate for tissue engineering. Their fibrous nature mimics biological tissues 273 
matrices at a microscopic scale compared to plain materials such as hydrogels. Many strategies were developed and 274 
characterized in an objective of delivering AC and cells to animals (see figure 7).  As mentioned, those concepts 275 
focused on the control of AC release from promising fibrous scaffolds have emerged and are summarized in the next 276 
section. 277 
A. Controlled release of AC from fibrous scaffolds 278 
Many different strategies exist to incorporate an AC into a fibrous material [60-62]. Most of them face a common 279 
problem of short release time which is problematic from a tissue engineering perspective. To tackle this problem, a 280 
first approach consists in using structured fibers. Novajra et al. [63] have recently developed a biodegradable 281 
scaffold based on hollow fibers of biodegradable glass for the long term release of neurotropic factors. Fibers were 282 
filled with genipin crosslinked agar/gelatin hydrogel in presence of fluorescein isothiocyanate-dextran (FD-20).  The 283 
authors did not report any correlation of the release rate and the fibers diameter since all of them achieved 100% 284 
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release of FD-20 after 24h. Also, no significant cytotoxicity of fiber dissolution products was reported on neonatal 285 
rat olfactory bulb ensheathing cell line. 286 
Another efficient strategy to develop structured fibers is to use mixture polymers during the electrospinning process. 287 
Bonani et al. [64] have developed a fibrous scaffold by making use of electrospun nanofibers of poly ε-caprolactone 288 
(PCL) and poly(D,L-lactide-co-glycolide acid) (PLGA). The authors designed different patterns of fibers of PCL 289 
and PLGA by spatially controlling their distribution on both side of the scaffold. Therefore, PLGA (with ending 290 
carboxylic group, PLGAac or with ester end group, PLGAes) polymers were loaded with either rhodamine B (RhB), 291 
fluorescein or tetra-methyl-rhodamine conjugated bovine serum albumin (AlbF and AlbT) to perform double-sided 292 
release. PLGAac-PCL and PLGAes-PCL releasing RhB (from a uniform gradient of PLGA-PCL polymers) both 293 
showed a majorly one-sided release with a burst effect.  PLGAes has demonstrated lower side release selectivity. 294 
Release of AlbT of PLGAac-PCL with the same gradient showed that 24% of protein was released in 24 hours and 295 
80% was released in 9 days on mainly one side only of the scaffold. After this period, the authors had estimated a 296 
constant release rate of AlbT of 1% per week. Moreover, the authors were able to sequentially release both proteins 297 
(AlbT and ALbF) by altering the materials distribution in the scaffold (see figure 8). Highest release rate of AlbT 298 
occurred at the first day, while AlbF release was delayed until day 5. A similar approach was used to release AlbT 299 
and AlbF each one from a different side of the scaffold. 300 
Alternatively, Lee et al. [65] successfully immobilized bone-forming peptide-1 BFP-1 on the surface of PLGA 301 
fibers coated with PDA and then characterized the differentiation of hMSCs into osteocytes and bone volume 302 
increase in mice calvarial defect models. hMSCs culture has shown for BFP-1 immobilized fibers higher cellular 303 
differentiation, calcium production and ALP activity than controls (PLGA and PLGA-PDA coated scaffolds). 304 
Similar correlations were also observed in vivo in the mice calvarial defect models. Immobilization of the growth 305 
factor at the surface of the fibrous scaffold significantly increased bone regeneration in animal model by potentially 306 
increasing cell differentiation and ALP activities, supported by in vitro results. 307 
Fibrous scaffold based on polyester polymers such as PLA, PLGA or PCL are most commonly used without any 308 
further modifications [66]. An improvement to this methodology is to build hybrid scaffolds incorporating different 309 
components within the fibers designed to perform very specific tasks. In that line of research, Lee et al. [67] have 310 
incorporated a self-assembled nanofiber gel of heparin-binding peptide amphiphiles (HBPA) and heparin-sulfate 311 
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(HS) into a porous collagen scaffold. The objective was to increase bone regeneration by mimicking biological 312 
BMP-2 signaling. The authors found that the natural affinity of BMP-2 to HBPA/HS complex made it able to 313 
modulate its release from the nanofibers gel. Implantation of the hybrid collagen scaffold loaded with low dose of 314 
BMP-2 significantly increased bone regeneration compared to controls in a rat model of femoral defect. These 315 
results clearly demonstrated that the architecture of the scaffold or its capacity to release AC are not the only crucial 316 
factors determining tissue regeneration. Incorporation of key signaling mechanism of the ECM can certainly amplify 317 
the regenerative capacity of growth factors as well.  318 
Silk fibers are increasingly used as scaffolds for their biodegradability, biocompatibility and mechanical properties 319 
and were found to be very suitable for bone tissue bioengineering [68-70].  Li et al. [71] designed a scaffold using 320 
electrospun silk fibers, poly(ethylene oxide) and incorporated nanoparticles of hydroxyapatite (silk/PEO/nHAP). 321 
BMP-2 was incorporated in the scaffold without any specific link and hMSCs were seeded on the surface of the 322 
scaffolds. Higher deposition of calcium and presence of bone-specific markers of differentiated hMSCs was 323 
observed and presence of nHAP further improved the results compared to controls. A similar scaffold developed by 324 
Biman et al. [72] utilized silk fibers embedded in polyacrylamide hydrogel. The authors showed, by using different 325 
fibers/hydrogel ratios, that the release rate of a model peptide (FITC linked inulin) increased significantly at higher 326 
concentration of fibroins in the scaffold. 327 
B. Encapsulation of cells into fibers 328 
Scaffold designed for cell delivery aim to recreate microenvironments with 3D cell-cell interaction of tissues. 329 
Promoting such 3D interaction might constitute a major leap for the treatment of a broad spectrum of degenerative 330 
diseases. Onoe et al. [73] developed a calcium alginate micro-fibrous hydrogel (Ca-alginate) embedding cells and 331 
ECM proteins. These fibers were generated from a double-coaxial microfluidic device with a flow of hydrogel and 332 
ECM with cells. Cells were then cultured until a cell fiber had being formed and the Ca-alginate was removed to 333 
obtain a cell-ECM fiber. Using a weaving and reeling technique, the authors were able to produce a scaffold with 334 
multiple cell fibers. This technology was then tested in diabetic mice model in the attempt to treat mellitus diabetes. 335 
The authors injected pepsin-solubilized type I collagen as ECM and fibers made of rat dissociated pancreatic cells 336 
and mouse pancreatic beta cells into the subrenal capsular space. After implantation, a significant decrease in blood 337 
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glucose concentration was found while upon removal, blood glucose levels were readjusted to their initial 338 
concentrations, demonstrating efficacy for diabetes treatment. Potentially, this technique is very promising for 339 
fibrous scaffolding in regenerative medicine because of its versatility of application along with its customizability of 340 
ECM patterning, cell type or cell line. 341 
Similarly, Wan et al. [74] fabricated an interesting multi-component hydrogel fibers made from water soluble chitin 342 
(WSC) and sodium alginate in a matrix of WSC, galactose and collagen to spatially co-culture differentiated human 343 
hepatocytes and endothelial cells. The resulting 3D fibrous scaffold was utilized for encapsulation and culture of 344 
differentiated cells and then implanted in mice where 70% of the original liver was removed. Human albumin in 345 
mice serum was detected at 2 and 4 weeks after implantation. The addition of structured endothelial cells to human 346 
hepatocytes on fibers increased albumin secretion in vivo. 347 
 Electrospun fibers recently received increased attention as a potential AC and cell encapsulating and delivering 348 
scaffold [75-78]. The capacity to guide cell adhesion and simulating native ECM makes this material attractive for 349 
various cellular applications. Mirahmadi et al. [79] prepared different hybrid scaffolds of chitosan/glycerophosphate 350 
(CS/GP) hydrogels by incorporating electrospun silk fibroins. No cytotoxicity was reported on seeded chondrocytes. 351 
Silk fibers incorporated in the scaffold increased glycosaminoglycan production after 21 days. This production was 352 
further increased by homogenous dispersions of silk fibers. Scaffolds comprising homogenously dispersed fibers in 353 
the hydrogels produced lower collagen II amount compared to a multi layered construct. The authors concluded that 354 
the multi-layer construct was the most suitable for collagen and proteoglycan deposit and therefore the most viable 355 
option for cartilage tissue engineering. 356 
Using a comparable method, Xiao et al. [80] incorporated different concentration of silk fibroins into a gelatin 357 
methacrylate (Gel-MA) hydrogel scaffold. NIH-3T3 cells were seeded on the surface of the scaffold. The authors 358 
showed that cell spreading was similar for all fiber concentrations tested, including blank Gel-MA hydrogels. Cell 359 
number was consequently higher among the lowest fiber concentrations and blank Gel-MA hydrogels. Interestingly, 360 
similar results for metabolic activities after 5 days were reported. Scaffolds presenting the lower fibroin 361 
concentration (5 mg.mL-1) in Gel-Ma hydrogels were displaying the best properties for regenerative medicine 362 
application. 363 
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C. Promoting regeneration with cells and growth factor delivery in fibrous 364 
scaffold  365 
As mentioned previously fiber electrospinning is a process suitable for creating fibers of various materials. The 366 
convenience of growth factors loading as well as simultaneous cells incorporation lead  Du et al. [81] in making use 367 
of CS/PCL electrospun nanofibers. By controlling the distribution of CS in the scaffold, either highly concentrated 368 
at the surface or homogeneously distributed, the authors were able to tune the distribution and release of VEGF from 369 
the scaffold. The release of VEGF was measured and the burst effect from the gradient scaffold was found 370 
approximately 42.5% reduced in comparison to uniformly loaded scaffold (see figure 9). After approximately 72 371 
hours, nearly 80% of the total loading was released scaffolds for both. Cytotoxicity assay on human umbilical vein 372 
endothelial cells (HUVECs) cultured on fibers was performed testing 4 preparations: both uniformed and gradient 373 
scaffolds with or without immobilized VEGFt. Gradient scaffold with VEGF presented significant increased cell 374 
growth compared to the three other scaffolds after 24h, 48h and 72h incubation time, but not after 4h and 12h (see 375 
figure 9). Co-culture of HUVECs and vascular smooth muscle cells (vSMCs) on the CS/PCL-VEGF gradient 376 
scaffold demonstrated that HUVEC were proliferating on the surface of the scaffold to form a monolayer, while 377 
vSMCs were growing at the bottom surface, forming a vascular-like structure. 378 
Alternatively, Lee et al. [82] combined photolithography and electrospun fibers of PCL/gelatin in a poly(ethylene 379 
glycol) (PEG) micropatterned hydrogel. According to the authors, the technique has the potential to release multiple 380 
growth factors in a controlled fashion to help stem cells to differentiate. The authors first synthesized PCL-gelatin 381 
fibers and then PEG hydrogel was micropatterned on the fibers by photopolymerisation in presence of bone 382 
morphogenetic protein-2 (BMP-2) in solution. The resulting composite gel was swollen into basic fibroblast growth 383 
factor (bFGF) solution in order to load bFGF on the surface of the exposed fibers. Both loaded growth factors 384 
(BMP-2 and bFGF) were released in PBS. The release of bFGF deposited on the fibers was faster with a significant 385 
burst during the first days, while BMP-2 entrapped in the hydrogel scaffold exhibited a slower burst extended over 5 386 
days. Both factors showed a slow release rate for 30 days after burst release. The authors demonstrated that hMSCs 387 
proliferated only on PCL/gelatin fibers and not on PEG micropatterns. BMP-2 and combination of BMP-2/bFGF 388 
significantly increased hMSCs differentiation compared to bFGF and control, suggesting that bFGF had no effect on 389 
both parameters. Faster differentiation into osteocytes was also correlated to stronger mineralisation.  390 
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Alternating layer of fibers may also be an interesting avenue to achieve a structured material capable of releasing 391 
AC and delivering stem cells. Manning et al. [83] created a scaffold alternating 11 layers of electrospun PLGA 392 
nanofiber and heparin/fibrin-based delivery system (HBDS). The release profile of platelet-derived growth factor 393 
(PDGF) was measured for fibrin and HDBS with and without fibers. PDGF was released faster from fibrin and 394 
slower for HDBS and fiber addition was found to have a versatile effect, decreasing the release rate with fibrin and 395 
increasing it for HDBS. In vivo cell viability tests using adipose stem cells were performed on adult mongrel dogs 396 
and shown successful cell delivery and viability after 9 days. 397 
Lee et al. [84] have demonstrated that hydroxyapatite mineralized polycaprolactone-gelatin fibers (PCL-gelatin), 398 
combined with a fibronectin fusion protein and osteocalcin (OCN), were able to stimulate hMSC functions. A 399 
release study of FN-OCN on non-mineralized fibers have shown that release was completed after 3 days, while for 400 
mineralized fibers only, 10-15% was released in 10 days, showing a more sustainable release. In vitro models, using 401 
hMSCs, comparing fibers with and without FN-OCN protein showed that cells were adhering and spreading faster in 402 
presence of FN-OCN protein. Further in vivo testing in a rat calvarium model showed that mineralized PCL-gelatin 403 
fibers with FN-OCN were increasing bone volume and density compared to PCL-gelatin without FN-OCN protein. 404 
Moreover, the addition of hMSCs and OCN in the scaffold further increased bone volume, but not density. 405 
Conclusion 406 
As we just described, fine control of AC release from a scaffold can be achieved in many different ways. The most 407 
commonly used strategies to date involve either the physical conjugation of AC to the scaffold, the encapsulation of 408 
the AC into a drug delivery system embedded into the scaffold or the direct incorporation of the AC into the 409 
scaffold. These approaches have shown to be able to modulate, to a certain extent, the release profile of the AC from 410 
a few hours to several weeks. Correlation between internal structure and AC release is the key parameter to use such 411 
scaffolds for tissue engineering and regenerative medicine applications. Mimicking internal architecture and AC 412 
regulation of native tissue allows controlling cells fate and organization which dictate neo-tissue properties. As we 413 
have seen, 2D gradient and patterning technologies have been developed for many years but their transition to 3D 414 
and 4D AC release is not yet achieved. Even if 3D printing, currently an important field of experimentations, and 415 
folding technique, a more recent explored phenomenon, show interesting properties for scaffold design, their 416 
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capacity for AC embedment still needs to be improved. Due to their tunable internal structure, hydrogels and fibers 417 
have been majorly used for regenerative medicine scaffold systems development. These systems complexity is 418 
increasing, resulting in a better control over AC release, but it could also be a drawback over their transition to 419 
clinical use. Future development of such systems will have to put emphasis on cells environment via controlled 420 
organization and multiple triggered AC release.  Nevertheless, besides the large body of work that have been 421 
reported, it is quite surprising to notice that only a few systematical studies have tried to quantitatively correlate AC 422 
release profile to cell differentiation and proliferation. In fact, the few existing studies, as we showed in this review, 423 
are performed in vitro and do not focus on such correlations yet. It is also interesting to notice that besides the 424 
extremely rich population of drug delivery systems that have been designed and tested in vivo, only a handful have 425 
been incorporated into an engineered scaffold. Such observation confirms that the control of AC release, in space 426 
and time (4D) can still be improved and explored in order to improve existing regenerative therapies. 427 
 428 
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 626 
Figure 1: AC and cells deposition processes in 2D 627 
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629 
Figure 2: Two-cell patterned co-culture, adapted from [39] 630 
 631 
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Figure 3: BAEP fabrication, adapted from [42] 633 
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 635 
Figure 4: Expected cumulative release of different cells/ACs distributions in hydrogel scaffolds 636 
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 638 
Figure 5: Strategies for tissue growth based on AC delivery 639 
640 
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 641 
Figure 6: Release curve of FGF (a), FGF loaded (b) and variation of GAG concentration (c) in different 642 
chitosan hydrogel treated by freeze drying and/or by gas foaming prior to layer-by-layer assembling of 643 
chondroitin sulfate and chitosan. Adapted from [56] 644 
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Figure 7: Representation of possible uses of fibrous scaffolds in drug encapsulation and in cell 653 
encapsulation. 654 
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Figure 8: PCL-PLGA scaffold for the sequential release of proteins. (A) Illustration of the compositional 668 
pattern of nanofibers. AlbF-loaded PLGA nanofibers were close to side B. (B) Cumulative release profile 669 
of ALbF and AlbT to both surfaces of the scaffold. (C) Net release profiles of AlbF and AlbT to side B 670 
during 12 days. Adapted from [64] 671 
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Figure 9:  Cumulative release of VEGF from the Heparinized uniform and gradient CS/PCL (left) and 679 
proliferation of HUVECs on the different nanofibrous scaffolds using the MTT assay (right) in function 680 
of incubation time. Adapted from [81] 681 
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